Bicycle, CR UK work together on new cancer drugs
Cancer Research UK, Cancer Research Technology (CRT) and UK biotech Bicycle Therapeutics have formed a pact to trial a first-in-class experimental drug for cancers of high unmet need.
Read More
Tag: drug conjugate
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
